Belite Bio, Inc
Belite Bio, Inc (BLTE) Stock Overview
Explore Belite Bio, Inc’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
-48.50
EPS (TTM)
$-1.36
ROE
-0.32%
BLTE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Belite Bio, Inc (BLTE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $91.22.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -48.50 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.